Deoxypyridinoline Crosslinks, Urine

What this laboratory test evaluates

DetailsDeoxypyridinoline Crosslinks, Urine – Monitor response to antiresorptive therapy in postmenopausal women and individuals with osteoporosis. Does not replace bone mineral density (BMD) screening to diagnose osteoporosis.

What type of sample is required for this test?3.5 mL aliquot from a well-mixed, first morning voided urine

Test ResourcesFor more information, please consult your healthcare provider.

Additional test information

Deoxypyridinoline Crosslinks, Urine – Monitor response to antiresorptive therapy in postmenopausal women and individuals with osteoporosis. Does not replace bone mineral density (BMD) screening to diagnose osteoporosis.

Collection and processing

• Sample type: Urine
• Fasting: No
• Estimated laboratory processing: Results should be available in 2 – 5 business days after the sample is collected

How Sunridge uses laboratory information

Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.

Before requesting this test

Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.